Expression of HLA-DR (major histocompatibility complex class II) on neutrophils from patients treated with granulocyte-macrophage colony-stimulating factor for mobilization of stem cells.
Mudzinski
S P
SP
Christian
T P
TP
Guo
T L
TL
Cirenza
E
E
Hazlett
K R
KR
Gosselin
E J
EJ
D002454:Cell Differentiation; D005786:Gene Expression Regulation / Q000187:drug effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009504:Neutrophils / Q000737:chemistry*
D006684:HLA-DR Antigens; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor